Search - tctmd.com

Displaying 21 - 40 of 130

Sort: Relevancy | Date

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Conference News EuroPCR 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

Shelley Wood

May 18, 2022

News Conference News EuroPCR 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Caitlin E. Cox

May 17, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Shelley Wood

March 14, 2022

News Daily News

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Caitlin E. Cox

March 08, 2022

News Conference News

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

Todd Neale

March 01, 2022

News Daily News

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Michael O'Riordan

February 25, 2022

News Conference News ESC 2021

PET Imaging Detects Degeneration After TAVI as Well as Surgical, Native Valves

Yael L. Maxwell

September 02, 2021

News Opinion CV Team Dispatch

July/August 2021 News Roundup

L.A. McKeown

August 01, 2021

News Daily News

NOTION at 8 Years: TAVI Still Comparable to Surgery

Yael L. Maxwell

July 08, 2021

News Conference News ACC 2021

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

Yael L. Maxwell

May 15, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Daily News

Published 2-Year Partner 3 Data Shed New Light on TAVI, SAVR Choice in Low-risk Patients

Yael L. Maxwell

March 02, 2021

Advertisement

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

PET Imaging Detects Degeneration After TAVI as Well as Surgical, Native Valves

July/August 2021 News Roundup

NOTION at 8 Years: TAVI Still Comparable to Surgery

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Published 2-Year Partner 3 Data Shed New Light on TAVI, SAVR Choice in Low-risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content